Detroit-based Henry Ford Health recently became the first in the world to complete a full course of patient treatments using the newest magnetic resonance-guided radiation therapy advancement, it said June 2.
The new technology, dubbed the MRIdian A3i, is the latest advancement to the MRIdian system from ViewRay. It allows for enhanced radiation beam tracking and only delivers the radiation when the tumor is in the treatment field, which protects healthy tissue by automatically stopping the beam when any target exceeds clinician-defined boundaries, according to an emailed news release from the system.
"People worldwide travel to Henry Ford Health for advanced cancer treatment," said Parag Parikh, MD, director of MR-guided radiation and GI radiation at Henry Ford Health System. "The precision and speed of MRIdian has made expedited treatments possible not only for prostate, breast and lung cancer, but also for traditionally challenging areas such as liver, pancreas, oligometastatic disease and reirradiation, with many of these treatment courses completing in one to two weeks."